Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Immunology

When Does Cancer Risk Start in Cartilage-Hair Hypoplasia?

At a Glance

In cartilage-hair hypoplasia (CHH), the risk of cancer begins in childhood and continues throughout life. Children and teens face an increased risk of blood cancers like lymphoma, while skin cancers typically appear in early adulthood, making early and lifelong screening essential.

In this answer

2 sections

01

The Timeline of Cancer Risk

02

Why Early Surveillance is Crucial

In cartilage-hair hypoplasia (CHH), the increased risk of cancer does not wait for adulthood — it begins in childhood and continues throughout life [1][2]. Because the timing of cancer onset varies widely depending on the type of cancer, medical experts emphasize that cancer surveillance must begin early in life and remain a lifelong commitment [3][2].

The Timeline of Cancer Risk

While CHH carries a lifelong risk of cancer [1][2], different types of malignancies tend to appear at different stages of life.

  • Childhood and Adolescence: The risk for certain blood cancers, particularly non-Hodgkin lymphoma (such as diffuse large B-cell lymphoma, or DLBCL, a fast-growing cancer of the white blood cells), can begin when a patient is still a child or teenager [1][2]. Lymphomas are the most common type of cancer reported in people with CHH [1][4]. These blood cancers are often associated with viral infections like the Epstein-Barr virus (EBV) [4].
  • Early Adulthood and Beyond: Cutaneous (skin) malignancies typically present in early adulthood. This includes basal cell carcinoma (a type of skin cancer that begins in the basal cells) [5][2]. Because of the weakened immune system, patients are also at risk for skin cancers, such as squamous cell carcinoma, associated with viral infections like the human papillomavirus (HPV) [5][1].

Why Early Surveillance is Crucial

It is a common misconception that you only need to screen for cancer if you have severe symptoms of an immune system defect. In reality, people with CHH can develop cancer even if they have mild immune symptoms or no prior clinical signs of immune deficiency [2][1].

Because lymphomas in CHH can be aggressive and are sometimes diagnosed at an advanced stage [1][2], early and regular oncological and immunological monitoring is critical for everyone with the condition, even those who feel perfectly healthy [3][2].

What Regular Monitoring Looks Like

While there is no single international protocol [1][6], surveillance usually means at least annual visits. This monitoring typically involves:

  • Physical exams to check for swollen lymph nodes, an enlarged spleen, or other physical warning signs.
  • Blood work to evaluate immune function and blood cell counts.
  • Annual skin checks with a dermatologist to catch abnormal moles or lesions early.

Navigating this care can feel overwhelming, so it is often best to have an immunologist or a medical geneticist serve as the “quarterback” of your care team, coordinating with your primary care doctor and other specialists [3][6].

Protecting Yourself Between Visits

While you cannot change your genetics, you can take proactive steps to reduce risks and catch issues early:

  • Sun Protection: Because of the high risk for early-adulthood skin cancers, strict sun protection (daily sunscreen, protective clothing, and seeking shade) is essential.
  • Vaccines: Discuss the HPV vaccine with your doctor, as it may offer protection against HPV-associated skin and mucosal cancers.
  • Know the Warning Signs: Contact your doctor between regular visits if you or your child experience persistent swollen lymph nodes, unexplained weight loss, extreme fatigue, night sweats, or new skin sores that do not heal.

Catching these conditions early provides the best chance for effective treatment, ensuring that you or your child can continue to lead a full and active life.

Common questions in this guide

At what age does cancer risk begin for someone with cartilage-hair hypoplasia?
The increased risk for cancer in CHH begins in childhood and lasts throughout a patient's life. Children and teenagers are particularly at risk for blood cancers like lymphoma, while skin cancers tend to develop in early adulthood.
Can I get cancer from CHH even if my immune system seems fine?
Yes, people with cartilage-hair hypoplasia can develop cancer even if they have mild immune symptoms or no previous signs of immune deficiency. This is why lifelong, regular cancer screening is crucial for everyone with the condition, even those who feel perfectly healthy.
What cancer screenings are needed for cartilage-hair hypoplasia?
While there is no single international protocol, regular monitoring usually involves at least annual doctor visits. These checkups typically include physical exams to check for swollen lymph nodes, blood work to evaluate immune function, and annual skin checks with a dermatologist.
How can I lower my risk of cancer with CHH?
You can take proactive steps by practicing strict sun protection every day and discussing the HPV vaccine with your doctor, which may protect against certain viral-associated cancers. It is also important to promptly report any warning signs, like persistent swollen lymph nodes or unexplained weight loss, to your healthcare team.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Who on my care team will coordinate my specialist referrals and manage my overall screening schedule?
  2. 2.What specific cancer screening tests and blood work should we be doing right now based on my (or my child's) age?
  3. 3.Should we see a dermatologist for regular skin checks, and how often should we schedule them?
  4. 4.Is the HPV vaccine recommended and safe for me (or my child), given my specific immune profile?
  5. 5.How do my current immune system lab results affect my individualized cancer screening timeline?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

What is the Long-Term Prognosis for Adults with CHH?Will My Child Need Surgery for Bowed Legs in CHH?Will My Child's Hair Grow in Cartilage-Hair Hypoplasia?What is the Life Expectancy for Cartilage-Hair Hypoplasia?How Does Cartilage-Hair Hypoplasia Affect Teeth & Gums?CHH vs. Achondroplasia: What Is The Difference?MDWH vs. Cartilage-Hair Hypoplasia: What's the Difference?How Does EBV Cause Lymphoma in CHH?Is Growth Hormone Safe for Cartilage-Hair Hypoplasia?Hirschsprung Disease Symptoms in CHH: What to Watch ForHow to Prepare for a CHH Specialist AppointmentWhy Does CHH Cause Macrocytic Anemia and How Is It Treated?Does Cartilage-Hair Hypoplasia Affect Male Fertility?How Does Cartilage-Hair Hypoplasia Affect Pregnancy?What Immune Support Is Needed for CHH?Does Cartilage-Hair Hypoplasia (CHH) Delay Puberty?When Is a Stem Cell Transplant Needed for CHH?Can Babies with Cartilage-Hair Hypoplasia Get Vaccines?Why is CHH Common in Amish & Finnish Populations?

References

References (6)
  1. 1

    Lymphomas in cartilage-hair hypoplasia - A case series of 16 patients reveals advanced stage DLBCL as the most common form.

    Kukkola HL, Utriainen P, Huttunen P, et al.

    Frontiers in immunology 2022; (13()):1004694 doi:10.3389/fimmu.2022.1004694.

    PMID: 36211439
  2. 2

    A 30-Year Prospective Follow-Up Study Reveals Risk Factors for Early Death in Cartilage-Hair Hypoplasia.

    Vakkilainen S, Taskinen M, Klemetti P, et al.

    Frontiers in immunology 2019; (10()):1581 doi:10.3389/fimmu.2019.01581.

    PMID: 31379817
  3. 3

    Immunodeficiency in cartilage-hair hypoplasia: Pathogenesis, clinical course and management.

    Vakkilainen S, Taskinen M, Mäkitie O

    Scandinavian journal of immunology 2020; (92(4)):e12913 doi:10.1111/sji.12913.

    PMID: 32506568
  4. 4

    Refractory/Relapsed Hodgkin Lymphoma in Cartilage Hair Hypoplasia-Anauxetic Dysplasia Spectrum: Long-term HSCT-free Remission in 2 Pediatric Siblings.

    Bukhari SI, Yazdani S, Fadoo Z

    Journal of pediatric hematology/oncology 2026; (48(2)):e91-e96 doi:10.1097/MPH.0000000000003158.

    PMID: 41460196
  5. 5

    Cartilage hair hypoplasia with cutaneous lymphomatoid granulomatosis.

    Sathishkumar D, Gach JE, Ogboli M, et al.

    Clinical and experimental dermatology 2018; (43(6)):713-717 doi:10.1111/ced.13543.

    PMID: 29744913
  6. 6

    Cartilage-hair hypoplasia with normal height in childhood-4 patients with a unique genotype.

    Klemetti P, Valta H, Kostjukovits S, et al.

    Clinical genetics 2017; (92(2)):204-207 doi:10.1111/cge.12969.

    PMID: 28094436

This page provides educational information about cancer risks associated with cartilage-hair hypoplasia. It does not replace professional medical advice. Always consult your genetics team or oncologist for personalized screening guidelines.

Get notified when new evidence is published on Cartilage-hair hypoplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.